Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $78.4M
Liabilities Breakdown FY2012
Total Liabilities: $42.8M
Asset Breakdown
Total Assets: $78.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $52.8M | 67.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.4M | 3.1% |
| Goodwill | $2.5M | 3.2% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $20.7M | 26.4% |
Liabilities Breakdown
Total Liabilities: $42.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.4M | 7.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $39.4M | 92.1% |